Wayne A. Bottner

492 total citations
18 papers, 297 citations indexed

About

Wayne A. Bottner is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Wayne A. Bottner has authored 18 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Genetics and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Wayne A. Bottner's work include Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and CAR-T cell therapy research (2 papers). Wayne A. Bottner is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and CAR-T cell therapy research (2 papers). Wayne A. Bottner collaborates with scholars based in United States. Wayne A. Bottner's co-authors include Michelle A. Mathiason, Kara J. Kallies, Jae Werndli, Brad S. Kahl, Jens C. Eickhoff, Jules H. Blank, Thomas McFarland, Howard H. Bailey, Walter Longo and Nirav Y. Patel and has published in prestigious journals such as Blood, Antimicrobial Agents and Chemotherapy and Annals of Oncology.

In The Last Decade

Wayne A. Bottner

18 papers receiving 289 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Wayne A. Bottner 137 124 89 71 41 18 297
Frank Hong 40 0.3× 41 0.3× 100 1.1× 184 2.6× 14 0.3× 21 286
Alberto Fragasso 133 1.0× 93 0.8× 114 1.3× 131 1.8× 11 0.3× 19 321
Vipulbhai Sakhiya 70 0.5× 59 0.5× 42 0.5× 57 0.8× 105 2.6× 9 260
Michael Gilbertson 243 1.8× 112 0.9× 172 1.9× 60 0.8× 20 0.5× 31 469
Robert Puckrin 78 0.6× 58 0.5× 44 0.5× 35 0.5× 52 1.3× 29 370
Deepa Dhawan 40 0.3× 51 0.4× 23 0.3× 16 0.2× 49 1.2× 21 330
Marie‐Thérèse Blouch 42 0.3× 21 0.2× 45 0.5× 83 1.2× 36 0.9× 9 380
Oludamilola Olajide 69 0.5× 149 1.2× 224 2.5× 152 2.1× 76 1.9× 16 519
Samantha Ferrari 94 0.7× 76 0.6× 28 0.3× 23 0.3× 22 0.5× 8 218
M. Mackie 38 0.3× 65 0.5× 111 1.2× 128 1.8× 158 3.9× 10 412

Countries citing papers authored by Wayne A. Bottner

Since Specialization
Citations

This map shows the geographic impact of Wayne A. Bottner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wayne A. Bottner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wayne A. Bottner more than expected).

Fields of papers citing papers by Wayne A. Bottner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wayne A. Bottner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wayne A. Bottner. The network helps show where Wayne A. Bottner may publish in the future.

Co-authorship network of co-authors of Wayne A. Bottner

This figure shows the co-authorship network connecting the top 25 collaborators of Wayne A. Bottner. A scholar is included among the top collaborators of Wayne A. Bottner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wayne A. Bottner. Wayne A. Bottner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Bottner, Wayne A., et al.. (2018). Severe, prolonged thrombocytopenia in a patient sensitive to exenatide. American Journal of Hematology. 94(3). E78–E80. 9 indexed citations
2.
Bottner, Wayne A., et al.. (2017). A follow‐up on desiderosmia (olfactory craving), a novel symptom associated with iron deficiency anemia. American Journal of Hematology. 92(9). E546–E546. 3 indexed citations
3.
Borgert, Andrew J., et al.. (2015). Long-term outcomes of an integrated transfusion reduction initiative in patients undergoing resection for colorectal cancer. The American Journal of Surgery. 210(6). 990–995. 9 indexed citations
4.
Go, Ronald S., Wayne A. Bottner, & Morie A. Gertz. (2015). Making the Case to Study the Volume-Outcome Relationship in Hematologic Cancers. Mayo Clinic Proceedings. 90(10). 1393–1399. 7 indexed citations
5.
Raghavendra, Meghana, et al.. (2014). Management of neutropenic fever during a transition from traditional hematology/oncology service to hospitalist care.. PubMed. 113(2). 53–8. 3 indexed citations
6.
Mathiason, Michelle A., et al.. (2012). The impact of an integrated transfusion reduction initiative in patients undergoing resection for colorectal cancer. The American Journal of Surgery. 204(6). 944–951. 21 indexed citations
7.
Patel, Nirav Y., et al.. (2012). Outcomes and complications after splenectomy for hematologic disorders. The American Journal of Surgery. 204(6). 1014–1020. 42 indexed citations
8.
Kenkre, Vaishalee P., Jens C. Eickhoff, Jules H. Blank, et al.. (2011). Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology Network. Leukemia & lymphoma. 52(9). 1675–1680. 30 indexed citations
9.
Chang, Julie, Jae Werndli, Wayne A. Bottner, et al.. (2010). Rituximab and CHOP Chemotherapy Plus GM-CSF for Previously Untreated Diffuse Large B-Cell Lymphoma in the Elderly: A Wisconsin Oncology Network Study. Clinical Lymphoma Myeloma & Leukemia. 10(5). 379–384. 13 indexed citations
10.
Go, Ronald S., Dean A. Jobe, Steven M. Callister, et al.. (2008). Circulating endothelial cells in patients with chronic lymphocytic leukemia. Annals of Hematology. 87(5). 369–373. 8 indexed citations
11.
Cole, Craig E., Jennifer Lee, Michelle A. Mathiason, et al.. (2007). Assessment of Psychological Distress in Patients Suffering from Hematological Disorders.. Blood. 110(11). 636–636. 6 indexed citations
12.
Kahl, Brad S., Walter Longo, Jens C. Eickhoff, et al.. (2006). Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology Network. Annals of Oncology. 17(9). 1418–1423. 82 indexed citations
13.
Go, Ronald S., et al.. (2005). Long-Term Follow up of Patients with Cold Agglutinin Disease.. Blood. 106(11). 3710–3710. 5 indexed citations
14.
Kahl, Brad S., Jules H. Blank, Anthony J. Jaslowski, et al.. (2004). Phase II Study of Modified Hyper-CVAD with Rituximab Maintenance for Previously Untreated Mantle Cell Lymphoma: A Wisconsin Oncology Network Study.. Blood. 104(11). 1388–1388. 9 indexed citations
15.
Landercasper, Jeffrey, et al.. (2004). Cholecystectomy and Acquired Factor VIII Inhibitor Coagulopathy. The American Surgeon. 70(9). 815–817. 8 indexed citations
16.
Go, Ronald S., et al.. (2004). Cranial vault lymphoma.. PubMed. 89(4). EIM06–EIM06. 7 indexed citations
17.
Schwartz, Carolyn E., et al.. (2003). Honing an Advance Care Planning Intervention Using Qualitative Analysis: The Living Well Interview. Journal of Palliative Medicine. 6(4). 593–603. 29 indexed citations
18.
Bottner, Wayne A., et al.. (1988). Comparative effects of cefoxitin and cefotetan on vitamin K metabolism. Antimicrobial Agents and Chemotherapy. 32(9). 1446–1449. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026